317 related articles for article (PubMed ID: 25645916)
1. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
[TBL] [Abstract][Full Text] [Related]
2. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.
Schulman JJ; Wright FA; Kaufmann T; Wojcikiewicz RJH
J Biol Chem; 2013 Aug; 288(35):25340-25349. PubMed ID: 23884412
[TBL] [Abstract][Full Text] [Related]
3. Remodeling of Ca
Ando H; Kawaai K; Bonneau B; Mikoshiba K
Adv Biol Regul; 2018 May; 68():64-76. PubMed ID: 29287955
[TBL] [Abstract][Full Text] [Related]
4. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
[TBL] [Abstract][Full Text] [Related]
5. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
[TBL] [Abstract][Full Text] [Related]
6. Targeting Bcl-2-IP
Distelhorst CW
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
[TBL] [Abstract][Full Text] [Related]
7. IP
Parys JB; Bultynck G; Vervliet T
Prog Mol Subcell Biol; 2021; 59():215-237. PubMed ID: 34050869
[TBL] [Abstract][Full Text] [Related]
8. 80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity.
Kawaai K; Hisatsune C; Kuroda Y; Mizutani A; Tashiro T; Mikoshiba K
J Biol Chem; 2009 Jan; 284(1):372-380. PubMed ID: 18990696
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Mechanisms of Endoplasmic Reticulum Resident IP3 Receptors.
Shah SZA; Zhao D; Khan SH; Yang L
J Mol Neurosci; 2015 Aug; 56(4):938-948. PubMed ID: 25859934
[TBL] [Abstract][Full Text] [Related]
10. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
[TBL] [Abstract][Full Text] [Related]
11. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
Akl H; Bultynck G
Biochim Biophys Acta; 2013 Apr; 1835(2):180-93. PubMed ID: 23232185
[TBL] [Abstract][Full Text] [Related]
12. IP
Rossi AM; Taylor CW
J Cell Sci; 2018 Dec; 132(4):. PubMed ID: 30552138
[TBL] [Abstract][Full Text] [Related]
13. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic Ca
Okubo Y
J Pharmacol Sci; 2020 Oct; 144(2):83-88. PubMed ID: 32709559
[TBL] [Abstract][Full Text] [Related]
15. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.
Vervloessem T; Yule DI; Bultynck G; Parys JB
Biochim Biophys Acta; 2015 Sep; 1853(9):1992-2005. PubMed ID: 25499268
[TBL] [Abstract][Full Text] [Related]
16. IP
Roest G; La Rovere RM; Bultynck G; Parys JB
Adv Exp Med Biol; 2017; 981():149-178. PubMed ID: 29594861
[TBL] [Abstract][Full Text] [Related]
17. IP
Bartok A; Weaver D; Golenár T; Nichtova Z; Katona M; Bánsághi S; Alzayady KJ; Thomas VK; Ando H; Mikoshiba K; Joseph SK; Yule DI; Csordás G; Hajnóczky G
Nat Commun; 2019 Aug; 10(1):3726. PubMed ID: 31427578
[TBL] [Abstract][Full Text] [Related]
18. Type 3 IP
Rosa N; Sneyers F; Parys JB; Bultynck G
Int Rev Cell Mol Biol; 2020; 351():101-148. PubMed ID: 32247578
[TBL] [Abstract][Full Text] [Related]
19. Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.
Steinmann C; Landsverk ML; Barral JM; Boehning D
J Biol Chem; 2008 May; 283(20):13506-9. PubMed ID: 18364356
[TBL] [Abstract][Full Text] [Related]
20. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.
Rong YP; Bultynck G; Aromolaran AS; Zhong F; Parys JB; De Smedt H; Mignery GA; Roderick HL; Bootman MD; Distelhorst CW
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14397-402. PubMed ID: 19706527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
